TABLE 2.
Descriptive analyses. Main characteristics of reports in COVID-19 and non-COVID-19 patients (1q-3q 2020).
| COVID-19 | Non-COVID-19 | ||
|---|---|---|---|
| Sex | Female | 2318 (37.1%) | 334645 (60.7%) |
| Male | 3935 (62.9%) | 217061 (39.3%) | |
| Missing | 829 | 85114 | |
| Country | United States | 4020 (56.8%) | 454568 (71.4%) |
| Spain | 714 (10.1%) | 5007 (0.7%) | |
| France | 587 (8.3%) | 13848 (2.2%) | |
| Italy | 468 (6.6%) | 7745 (1.2%) | |
| Switzerland | 150 (2.1%) | 7776 (1.2%) | |
| Other/Missing | 1143 | 147876 | |
| Occupation | Pharmacist | 2822 (42.1%) | 44190 (7.2%) |
| Medical doctor | 1747 (26.1%) | 119344 (19.4%) | |
| Healthcare practitioner | 1592 (23.8%) | 145116 (23.6%) | |
| Consumer | 536 (8.0%) | 298649 (48.6%) | |
| Lawyer | 0 (0.0%) | 7121 (1.2%) | |
| Missing | 385 | 22400 | |
| Report code | Expedited | 4306 (60.8%) | 314980 (49.5%) |
| Direct | 2684 (37.9%) | 46074 (7.2%) | |
| Periodic | 92 (1.3%) | 275766 (43.3%) | |
| Age group | Elderly | 2519 (41.2%) | 124936 (35.4%) |
| Adult | 3467 (56.7%) | 202124 (57.3%) | |
| Teenager | 61 (1.0%) | 13740 (3.9%) | |
| Child | 41 (0.7%) | 7307 (2.1%) | |
| Infant | 21 (0.3%) | 3671 (1.0%) | |
| Newborn | 4 (0.1%) | 695 (0.2%) | |
| Missing | 969 | 284347 | |
| First report | Jan | 0 (0.0%) | 60556 (9.5%) |
| Feb | 4 (0.1%) | 66473 (10.4%) | |
| Mar | 51 (0.7%) | 72611 (11.4%) | |
| Apr | 420 (5.9%) | 71408 (11.2%) | |
| May | 1219 (17.2%) | 69718 (10.9%) | |
| Jun | 1647 (23.3%) | 75001 (11.8%) | |
| Jul | 1483 (20.9%) | 77772 (12.2%) | |
| Aug | 1177 (16.6%) | 69309 (10.9%) | |
| Sep | 1081 (15.3%) | 73972 (11.6%) | |
| Outcome | Death | 1690 (23.9%) | 54071 (8.5%) |
| Life-threatening | 470 (6.6%) | 12785 (2.0%) | |
| Disability | 49 (0.8%) | 6828 (1.1%) | |
| Required-intervention | 38 (0.6%) | 371 (0.1%) | |
| Hospitalization | 1176 (19.2%) | 108805 (17.1%) | |
| Congenital anomaly | 3 (0.0%) | 1253 (0.2%) | |
| Other serious | 2696 (44.0%) | 166439 (26.1%) | |
| No seriousness specified | 960 (13.6%) | 286268 (45.0%) |